ATE276754T1 - Neue fluoreszensfarbstoffe und ihre anwendung in fluoreszensnachweisverfahren ganzer zellen für kaspasen, peptidasen, proteasen und andere enzyme sowie deren verwendung - Google Patents

Neue fluoreszensfarbstoffe und ihre anwendung in fluoreszensnachweisverfahren ganzer zellen für kaspasen, peptidasen, proteasen und andere enzyme sowie deren verwendung

Info

Publication number
ATE276754T1
ATE276754T1 AT99935751T AT99935751T ATE276754T1 AT E276754 T1 ATE276754 T1 AT E276754T1 AT 99935751 T AT99935751 T AT 99935751T AT 99935751 T AT99935751 T AT 99935751T AT E276754 T1 ATE276754 T1 AT E276754T1
Authority
AT
Austria
Prior art keywords
protease
caspases
reporter molecules
enzymes
peptidases
Prior art date
Application number
AT99935751T
Other languages
English (en)
Inventor
Han-Zhong Zhang
Sui Xiong Cai
John A Drewe
Wu Yang
Original Assignee
Cytovia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytovia Inc filed Critical Cytovia Inc
Application granted granted Critical
Publication of ATE276754T1 publication Critical patent/ATE276754T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT99935751T 1998-07-21 1999-07-21 Neue fluoreszensfarbstoffe und ihre anwendung in fluoreszensnachweisverfahren ganzer zellen für kaspasen, peptidasen, proteasen und andere enzyme sowie deren verwendung ATE276754T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9364298P 1998-07-21 1998-07-21
PCT/US1999/016423 WO2000004914A1 (en) 1998-07-21 1999-07-21 Novel fluorescence dyes and their applications for whole cell fluorescence screening assays for caspases, peptidases, proteases and other enzymes and the use thereof

Publications (1)

Publication Number Publication Date
ATE276754T1 true ATE276754T1 (de) 2004-10-15

Family

ID=22240008

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99935751T ATE276754T1 (de) 1998-07-21 1999-07-21 Neue fluoreszensfarbstoffe und ihre anwendung in fluoreszensnachweisverfahren ganzer zellen für kaspasen, peptidasen, proteasen und andere enzyme sowie deren verwendung

Country Status (6)

Country Link
US (2) US6248904B1 (de)
EP (1) EP1100520B1 (de)
AT (1) ATE276754T1 (de)
AU (1) AU5116099A (de)
DE (1) DE69920473T2 (de)
WO (1) WO2000004914A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001018238A1 (en) * 1999-09-10 2001-03-15 Oncoimmunin, Inc. Compositions for the detection of enzyme activity in biological samples and methods of use thereof
US6517781B1 (en) * 1997-06-02 2003-02-11 Aurora Biosciences Corporation Low fluorescence assay platforms and related methods for drug discovery
EA200000408A1 (ru) * 1997-10-10 2000-12-25 Сайтовиэ, Инк. Новые флуоресцентные сигнальные молекулы и их применение, в том числе, в анализах каспаз
US6342611B1 (en) * 1997-10-10 2002-01-29 Cytovia, Inc. Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
ATE276754T1 (de) 1998-07-21 2004-10-15 Cytovia Inc Neue fluoreszensfarbstoffe und ihre anwendung in fluoreszensnachweisverfahren ganzer zellen für kaspasen, peptidasen, proteasen und andere enzyme sowie deren verwendung
US6391575B1 (en) * 1999-03-05 2002-05-21 Idun Pharmaceuticals, Inc. Methods for detecting membrane derived caspase activity and modulators thereof
US6524797B1 (en) * 1999-05-10 2003-02-25 Bernhard O. Palsson Methods of identifying therapeutic compounds in a genetically defined setting
US20040121941A1 (en) * 1999-09-28 2004-06-24 Burm Brigitte Elisa Anna Novel inhibitors of prenylated pyrophosphate consuming enzymes
CA2410898A1 (en) * 2000-07-19 2002-01-24 Pharmacia & Upjohn Company Substrates and assays for .beta.-secretase activity
WO2002012545A2 (en) 2000-08-03 2002-02-14 Cytovia, Inc. Method of identifying immunosuppressive agents
US7083945B1 (en) * 2000-10-27 2006-08-01 The Board Of Regents Of The University Of Texas System Isolation of binding proteins with high affinity to ligands
US6979530B2 (en) * 2001-05-21 2005-12-27 Applera Corporation Peptide conjugates and fluorescence detection methods for intracellular caspase assay
EP1417328A2 (de) * 2001-07-20 2004-05-12 Children's Medical Center Corporation Invasionskomplex und targeting-verfahren
US7291698B2 (en) * 2001-09-04 2007-11-06 Stephen Eliot Zweig Synthetic substrate for high specificity enzymatic assays
US7026111B2 (en) 2001-10-15 2006-04-11 Beckman Coulter, Inc. Methods and reagents for improved cell-based assays
WO2003061711A2 (en) * 2002-01-16 2003-07-31 Visen Medical, Inc. Chromophore probes for optical imaging
US7927871B2 (en) * 2002-01-29 2011-04-19 Oncoimmunin, Inc. Visualization and quantitation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markers
JP2005527209A (ja) 2002-04-22 2005-09-15 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 疼痛管理のためのプロテインキナーゼＣγのペプチドインヒビター
US6933275B2 (en) 2002-05-01 2005-08-23 The Board Of Trustees Of The Leland Stanford Junior University Protein kinase C peptides for use in withdrawal
WO2003099780A2 (en) * 2002-05-24 2003-12-04 Molecular Devices Corporation Luminogenic protease substrates
WO2004003510A2 (en) * 2002-07-01 2004-01-08 Guava Technologies, Inc. Fluorescent dyes, energy transfer couples and methods
US7118877B2 (en) * 2002-07-08 2006-10-10 Wyeth Caspase 9 activation and uses therefor
US7195884B2 (en) * 2002-07-19 2007-03-27 Promega Corp. Methods and kits for transferases
US6821744B2 (en) 2002-10-29 2004-11-23 Roche Diagnostics Operations, Inc. Method, assay, and kit for quantifying HIV protease inhibitors
CA2523517C (en) * 2003-04-25 2013-07-30 Dana-Farber Cancer Institute, Inc. Bcl2l12 polypeptide activators and inhibitors
EP1628674A2 (de) 2003-05-06 2006-03-01 Cytovia, Inc. Protease-hemmer für coronaviren und sars-cov und ihre verwendung
WO2004103266A2 (en) * 2003-05-16 2004-12-02 The Board Of Trustees Of The Leland Stanford Junior University Protein kinase c peptides for use in withdrawal
EP1598428A1 (de) 2004-05-18 2005-11-23 Georg Dewald Verfahren und Kits zum Nachweis von erblichen angioedema typ III
CN101223187A (zh) * 2004-11-24 2008-07-16 萨拉普托斯股份公司 用作双重胱天蛋白酶-2/-6抑制剂的新肽及其生物学应用
US7947256B2 (en) * 2005-09-02 2011-05-24 Visen Medical, Inc. Biocompatible fluorescent imaging agents
EP1934202B1 (de) * 2005-09-02 2019-01-09 Visen Medical, Inc. Nah-infrarot-fluorophore, die sich von nicotinsäure und picolinsäure ableiten
CA2621137C (en) * 2005-09-02 2014-07-29 Visen Medical, Inc. Biocompatible n,n-disubstituted sulfonamide-containing fluorescent dye labels
US7452973B2 (en) * 2005-11-07 2008-11-18 Wisconsin Alumni Research Foundation Cell-permeable fluorescent proteins
US7897401B2 (en) * 2005-11-29 2011-03-01 University Of Maryland, College Park Control of apoptosis by controlling the propensity of ceramide channel formation
KR100909996B1 (ko) 2007-09-19 2009-07-29 한국생명공학연구원 카스파제-3(ｃａｓｐａｓｅ-3)의 활성 검출용 융합 단백질및 이를 이용한 카스파제-3의 활성 검출방법
US8679836B2 (en) * 2007-10-01 2014-03-25 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of monitoring angiogenesis and metastasis in three dimensional co-cultures
US20090088341A1 (en) * 2007-10-01 2009-04-02 The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health & Human Services Multiplex assay method for mixed cell populations
ES2498674T3 (es) * 2007-11-09 2014-09-25 Genzyme Corporation Métodos para medir la viabilidad celular sin usar células de control
US9249231B2 (en) 2010-11-05 2016-02-02 Cell Signaling Technology, Inc. Motif-specific and context-independent antibodies that specifically bind to a cleaved caspase motif
RU2482128C1 (ru) * 2011-12-28 2013-05-20 Замертон Холдингс Лимитед Пептиды, обладающие цитопротекторной активностью
ES2685402T3 (es) * 2013-07-18 2018-10-08 Chr. Hansen A/S Composición de enzima proteasa aspártica para coagulación de leche
US10106818B2 (en) 2013-08-16 2018-10-23 The J. David Gladstone Institutes Dual-color HIV reporter system for the detection of latently-infected cells
WO2019117812A1 (en) * 2017-12-12 2019-06-20 Nanyang Technological University Near infra-red molecular probes for use in diagnosis of fibrotic conditions and screening of anti-fibrotic drugs
KR102186097B1 (ko) * 2017-12-26 2020-12-03 주식회사 엘지화학 잔텐계 화합물 및 이를 포함하는 감광성 수지 조성물
WO2020053808A1 (en) 2018-09-12 2020-03-19 Georg Dewald Method of diagnosing vasoregulatory disorders

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
US4044126A (en) * 1972-04-20 1977-08-23 Allen & Hanburys Limited Steroidal aerosol compositions and process for the preparation thereof
US4336186A (en) 1978-08-03 1982-06-22 Gargiulo Robert J Analytical fluorogenic substrates for proteolytic enzymes
US4500471A (en) 1980-04-16 1985-02-19 Occidental Chemical Corporation Preparation of trifluoromethyl-benzoyl halides
JPS588769A (ja) 1981-07-08 1983-01-18 Ricoh Co Ltd インクジエツト記録用インク組成物
US4522811A (en) * 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4640893A (en) 1983-10-28 1987-02-03 University Of Illinois Novel rhodamine derivatives as fluorogenic substrates for proteinases
US4557862A (en) * 1983-10-28 1985-12-10 University Patents, Inc. Rhodamine derivatives as fluorogenic substrates for proteinases
DE3531272C2 (de) 1985-09-02 1997-09-25 Basf Ag Verfahren zur Herstellung von veresterten Rhodamin-Farbstoffen
US4900686A (en) 1987-04-02 1990-02-13 Polaroid Corporation Fluorescent conjugates and biological diagnostic assay
DE3916729A1 (de) 1989-05-23 1990-12-06 Behringwerke Ag Fluorogene verbindungen und ihre verwendung
US5587490A (en) 1990-04-16 1996-12-24 Credit Managers Association Of California Method of inactivation of viral and bacterial blood contaminants
US5227487A (en) 1990-04-16 1993-07-13 Molecular Probes, Inc. Certain tricyclic and pentacyclic-hetero nitrogen rhodol dyes
US5208148A (en) 1990-12-07 1993-05-04 Molecular Probes, Inc. Lipophilic fluorescent glycosidase substrates
JP3130935B2 (ja) 1991-06-24 2001-01-31 ゼネカ リミテッド 医薬組成物
US6348570B1 (en) 1991-08-16 2002-02-19 Merck & Co., Inc. Chromophore containing compounds and their use in determining interleukin-1β convertase activity
DE69229174T2 (de) * 1991-08-23 1999-09-16 Molecular Probes, Inc. Verwendung von haloalkylderivaten von reportermolekülen zur analyse der metabolischen aktivität in zellen
US5316906A (en) 1991-08-23 1994-05-31 Molecular Probes, Inc. Enzymatic analysis using substrates that yield fluorescent precipitates
US5576424A (en) 1991-08-23 1996-11-19 Molecular Probes, Inc. Haloalkyl derivatives of reporter molecules used to analyze metabolic activity in cells
JPH07501444A (ja) 1991-11-12 1995-02-16 プロメガ コーポレイション 非放射性酵素検定
AU5102993A (en) 1992-09-18 1994-04-12 Merck & Co., Inc. Dna encoding murine precursor interleukin 1beta converting enzyme
EP0623599A1 (de) 1993-03-26 1994-11-09 Ciba-Geigy Ag Optischer Sensor zur Bestimmung von Kationen
US6087160A (en) 1993-06-24 2000-07-11 The General Hospital Corporation Programmed cell death genes and proteins
US5659024A (en) 1994-01-14 1997-08-19 The Burnham Institute Promotors that regulate the expression of genes involved in cell death
US5556992A (en) 1994-09-02 1996-09-17 Universite De Montreal Novel rhodamine derivatives for photodynamic therapy of cancer and in vitro purging of the leukemias
US5605809A (en) 1994-10-28 1997-02-25 Oncoimmunin, Inc. Compositions for the detection of proteases in biological samples and methods of use thereof
US5843635A (en) 1995-02-27 1998-12-01 Dana-Farber Cancer Institute, Inc. Inhibition of APC-mediated apoptosis of activated T lymphocytes
US5798442A (en) 1995-04-21 1998-08-25 Merck Frosst Canada, Inc. Peptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinases
US5698411A (en) 1995-05-18 1997-12-16 Coulter Corporation Method for determining activity of enzymes in metabolically active whole cells
US5871946A (en) 1995-05-18 1999-02-16 Coulter Corporation Method for determining activity of enzymes in metabolically active whole cells
US5976822A (en) * 1995-05-18 1999-11-02 Coulter International Corp. Method and reagent for monitoring apoptosis and distinguishing apoptosis from necrosis
JPH11505702A (ja) 1995-05-18 1999-05-25 コールター インターナショナル コーポレイション アッセイ試薬及び前記アッセイ試薬の製造及び使用方法
US5733719A (en) 1995-05-18 1998-03-31 Coulter Corporation Method of making an assay compound
US5776720A (en) 1995-05-18 1998-07-07 Coulter Corporation Assay reagent
US5834216A (en) * 1995-09-06 1998-11-10 Arch Development Corporation Screening methods for the identification of inducers and inhibitors of programmed cell death (apoptosis)
WO1997011067A1 (en) 1995-09-21 1997-03-27 Novartis Ag Polymer-bound fluorophores as optical ion sensors
US6200969B1 (en) * 1996-09-12 2001-03-13 Idun Pharmaceuticals, Inc. Inhibition of apoptosis using interleukin-1β-converting enzyme (ICE)/CED-3 family inhibitors
DE19639450A1 (de) 1996-09-25 1998-04-09 Deutsches Krebsforsch Verfahren zum diagnostischen Nachweis von Apoptose in Zellen
US5897992A (en) 1996-09-27 1999-04-27 Cold Spring Harbor Laboratory Cell-free assay using oncogene-induced apoptosis in drug-resistant cells
US5773236A (en) * 1997-04-25 1998-06-30 Molecule Probes, Inc. Assay for glutathiane transferase using polyhaloaryl-substituted reporter molecules
US6270980B1 (en) 1997-06-05 2001-08-07 Idun Pharmaceuticals, Inc. Rapid methods for identifying modifiers of cellular apoptosis activity
WO1998057664A1 (en) 1997-06-19 1998-12-23 The General Hospital Corporation Interleukin converting enzyme (ice) and central nervous system damage
EA200000408A1 (ru) 1997-10-10 2000-12-25 Сайтовиэ, Инк. Новые флуоресцентные сигнальные молекулы и их применение, в том числе, в анализах каспаз
US6184210B1 (en) * 1997-10-10 2001-02-06 Cytovia, Inc. Dipeptide apoptosis inhibitors and the use thereof
US6342611B1 (en) * 1997-10-10 2002-01-29 Cytovia, Inc. Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
KR20010041905A (ko) * 1998-03-16 2001-05-25 시토비아 인크. 디펩티드 카스파제 억제제 및 이의 용도
ATE276754T1 (de) * 1998-07-21 2004-10-15 Cytovia Inc Neue fluoreszensfarbstoffe und ihre anwendung in fluoreszensnachweisverfahren ganzer zellen für kaspasen, peptidasen, proteasen und andere enzyme sowie deren verwendung
AU2864100A (en) 1999-02-01 2000-08-18 Cytovia, Inc. Methods of identifying therapeutically effective antineoplastic agents with cultured cells having intact cell membranes and corresponding products
AU3876600A (en) * 1999-03-16 2000-10-04 Cytovia, Inc. Substituted 2-aminobenzamide caspase inhibitors and the use thereof
US6355618B1 (en) * 1999-04-09 2002-03-12 Cytovia, Inc. Caspase inhibitors and the use thereof
US6462041B1 (en) * 1999-05-21 2002-10-08 Cytovia, Inc. Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis
US6495522B1 (en) * 1999-08-27 2002-12-17 Cytovia, Inc. Substituted alpha-hydroxy acid caspase inhibitors and the use thereof
US6566338B1 (en) * 1999-10-12 2003-05-20 Cytovia, Inc. Caspase inhibitors for the treatment and prevention of chemotherapy and radiation therapy induced cell death

Also Published As

Publication number Publication date
US6984718B2 (en) 2006-01-10
US6248904B1 (en) 2001-06-19
EP1100520A1 (de) 2001-05-23
WO2000004914A1 (en) 2000-02-03
DE69920473D1 (de) 2004-10-28
AU5116099A (en) 2000-02-14
DE69920473T2 (de) 2006-02-23
EP1100520A4 (de) 2002-07-17
EP1100520B1 (de) 2004-09-22
US20030208037A1 (en) 2003-11-06

Similar Documents

Publication Publication Date Title
ATE276754T1 (de) Neue fluoreszensfarbstoffe und ihre anwendung in fluoreszensnachweisverfahren ganzer zellen für kaspasen, peptidasen, proteasen und andere enzyme sowie deren verwendung
HUP0100079A2 (hu) Új, fluoreszcens riportermolekulák és alkalmazásaik, többek között kaszpázok vizsgálatára
Harwood et al. Caspase and calpain function in cell death: bridging the gap between apoptosis and necrosis
Wilkesman et al. Protease analysis by zymography: a review on techniques and patents
Cai et al. Design and synthesis of rhodamine 110 derivative and caspase-3 substrate for enzyme and cell-based fluorescent assay
DE60238132D1 (de) Patientenklassifizierung
ATE345399T1 (de) Biomarker und targets für die diagnose, prognose und behandlung von prostat krankheiten
WO2003106974A3 (en) Diagnosis and treatment of chemoresistant tumors
ATE454468T1 (de) Nachweis der instabilität von mikrosatelliten und verwendung davon bei der tumordiagnose
Lohmüller et al. Toward computer-based cleavage site prediction of cysteine endopeptidases.
Strucksberg et al. Proteasomal activity in skeletal muscle: a matter of assay design, muscle type, and age
Capone et al. Characterization of metalloproteinases, oxidative status and inflammation levels in the different stages of fibrosis in HCV patients
WO2002063271A8 (en) Activity based probe analysis
Fujihara et al. Circulating cell-free DNA fragment analysis by microchip electrophoresis and its relationship with DNase I in cardiac diseases
ATE220110T1 (de) Assays und reaganzien zur identifizierung von fungiziden wirkstoffen und ihre verwendungen
US7026111B2 (en) Methods and reagents for improved cell-based assays
ATE145672T1 (de) Neue inhibitoren für hydrolytische enzyme und substrate und bestimmungsverfahren, selbige einschliessende verfahren und testsätze
Goldenberg et al. Strategies for the identification of ubiquitin ligase inhibitors
JP6360848B2 (ja) ライソゾーム病３疾患責任酵素の迅速マススクリーニング検査法
Kohan et al. Palmitoyl Protein Thioesterase1 (PPT1) and Tripeptidyl Peptidase-I (TPP-I) are expressed in the human saliva. A reliable and non-invasive source for the diagnosis of infantile (CLN1) and late infantile (CLN2) neuronal ceroid lipofuscinoses
Wilkesman et al. Advances in zymography techniques and patents regarding protease analysis
FR2875242B1 (fr) Nouveaux substrats enzymatiques derives de phenoxazinone et leur utilisation comme revelateur dans la detection de microorganismes a activite peptidase
Ganesh et al. Flow cytometric determination of aminopeptidase activities in viable cells using fluorogenic rhodamine 110 substrates
RU2528100C1 (ru) Способ прогнозирования развития гематогенных метастазов после комбинированного лечения рака почки
DE60234991D1 (de) Verwendung des slug-gens oder der transkriptions- oder expressionsprodukte davon beim nachweis und/oder bei der behandlung von krebsartigen zellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties